Efficacy and safety of finerenone according to frailty in patients with heart failure: a prespecified analysis of the FINEARTS-HF trial

18 May 2025 (16:00 - 16:45)
Organised by: Logo
Congress Presentation Part of: Inflammation, frailty, and vascular function: exploring prognostic and therapeutic strategies Comorbidities HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by